Rachael Thorneloe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rachael Thorneloe has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Christopher Ernest Maitland Griffiths
Centre for Dermatology Research, NIHR Manchester Biomedical Research Centre, Manchester Academic Health Science Centre University of Manchester Manchester UK
6 shared publications - Lis Cordingley
University of Manchester, Manchester, UK
6 shared publications - Christine Bundy
School of Healthcare Sciences, Cardiff University , Cardiff
4 shared publications - Darren M. Ashcroft
Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
4 shared publications - Madelynne A. Arden
Centre for Behavioural Science and Applied Psychology, Sheffield Hallam University, Sheffield, UK
4 shared publications - Kelly Lloyd
Leeds Institute of Health Sciences, University of Leeds, Leeds, UK
3 shared publications
Latest Publications
- Open Access
- 25 June 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Analysing Content and Mechanisms of Action of Online Co-parenting Interventions: A Systematic Review (Preprint)
BACKGROUND Face-to-face co-parenting interventions have been shown to improve outcomes for parents and children after separation or divorce. Online co-parenting interventions are a flexible and scalable alternative for parents navigating multiple other stressors. However, there is little understanding about how their content leads to positive behaviour change. OBJECTIVE The objective of this systematic review was to explore how behavioural science could be incorporated into the content of online co-parenting interventions by analysing their active ingredients, (or âbehaviour change techniques â BCTs) and potential mechanisms of action. METHODS Eligibility criteria: Studies were included if they evaluated or described interventions for parents who were separating or divorced, were delivered online, and evaluated at least one psychological outcome. Information sources: Five databases - Web of Science, Medline, PubMed, PsychInfo and ProQuest - and grey literature were searched in March 2024. Search results were exported to Covidence, where twenty percent of the results were screened by a second reviewer. Risk of Bias: Risk of bias was evaluated using the Mixed Methods Appraisal Tool by two authors. Synthesis methods: Select items from the Behaviour Change Intervention Ontology (BCIO) and Template for Intervention Description and Replication (TIDieR) checklist were used to extract components of the intervention. Results were synthesised after classifying interventions as very promising, promising, and possibly promising based on the risk of bias and positive outcomes. RESULTS 14 interventions represented by 24 studies were included in the review. Positive outcomes were observed for asynchronous and synchronous interventions across different levels of interactivity, dosage and tailoring. Interventions that used behaviour change theories were promising in their effectiveness. Across the 14 interventions, 22 BCTs were identified. BCTs used in promising interventions were âGuide how to perform behaviourâ and âAwareness of other peoples thoughts, feelings and actionsâ. Other frequently coded BCTs were âGoal-directedâ, âIncrease awareness of consequencesâ, âMonitoringâ , âSocial supportâ and âSuggest different perspective on behaviourâ BCTs. The content of the interventions most frequently targeted parentsâ motivation to change their behaviours, followed by their psychological capability and social opportunity. CONCLUSIONS The most frequent sources of bias were the lack in clarity in how randomisation was being performed and incomplete outcome data due to high drop-out rates in the trials. The studies did not provide evidence for the effectiveness of these interventions for parents from low- and middle-income countries. This review provides evidence to support the role of behavioural science in developing evidence-based online co-parenting interventions. CLINICALTRIAL The protocol was prospectively registered on PROSPERO (CRD42024511486)
- 25 June 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessAnalysing Content and Mechanisms of Action of Online Co-parenting Interventions: A Systematic Review (Preprint)
BACKGROUND Face-to-face co-parenting interventions have been shown to improve outcomes for parents and children after separation or divorce. Online co-parenting interventions are a flexible and scalable alternative for parents navigating multiple other stressors. However, there is little understanding about how their content leads to positive behaviour change. OBJECTIVE The objective of this systematic review was to explore how behavioural science could be incorporated into the content of online co-parenting interventions by analysing their active ingredients, (or âbehaviour change techniques â BCTs) and potential mechanisms of action. METHODS Eligibility criteria: Studies were included if they evaluated or described interventions for parents who were separating or divorced, were delivered online, and evaluated at least one psychological outcome. Information sources: Five databases - Web of Science, Medline, PubMed, PsychInfo and ProQuest - and grey literature were searched in March 2024. Search results were exported to Covidence, where twenty percent of the results were screened by a second reviewer. Risk of Bias: Risk of bias was evaluated using the Mixed Methods Appraisal Tool by two authors. Synthesis methods: Select items from the Behaviour Change Intervention Ontology (BCIO) and Template for Intervention Description and Replication (TIDieR) checklist were used to extract components of the intervention. Results were synthesised after classifying interventions as very promising, promising, and possibly promising based on the risk of bias and positive outcomes. RESULTS 14 interventions represented by 24 studies were included in the review. Positive outcomes were observed for asynchronous and synchronous interventions across different levels of interactivity, dosage and tailoring. Interventions that used behaviour change theories were promising in their effectiveness. Across the 14 interventions, 22 BCTs were identified. BCTs used in promising interventions were âGuide how to perform behaviourâ and âAwareness of other peoples thoughts, feelings and actionsâ. Other frequently coded BCTs were âGoal-directedâ, âIncrease awareness of consequencesâ, âMonitoringâ , âSocial supportâ and âSuggest different perspective on behaviourâ BCTs. The content of the interventions most frequently targeted parentsâ motivation to change their behaviours, followed by their psychological capability and social opportunity. CONCLUSIONS The most frequent sources of bias were the lack in clarity in how randomisation was being performed and incomplete outcome data due to high drop-out rates in the trials. The studies did not provide evidence for the effectiveness of these interventions for parents from low- and middle-income countries. This review provides evidence to support the role of behavioural science in developing evidence-based online co-parenting interventions. CLINICALTRIAL The protocol was prospectively registered on PROSPERO (CRD42024511486)
- Open Access
- 22 March 2022
- Published by Springer Nature in BMC Public Health
- Vol. 22  (1) , 1-11
Adherence to behaviours associated with the test, trace, and isolate system: an analysis using the theoretical domains framework
Background: The UKâs test, trace, and isolate system are key measures to reduce the impact and spread of COVID-19. However, engagement with and adherence to guidance on testing, self-isolation, and providing details of contacts can be low and interventions are needed. This qualitative study aimed to identify the key factors affecting adherence to test, trace, and isolate behaviours using the Theoretical Domains Framework (TDF). Methods: We conducted six online focus groups between October 2020 and February 2021 with people living in Sheffield who came into close contact with others in work or social settings (N = 30). The focus groups explored capability, opportunity, and motivational barriers to adherence to test, trace, and isolate behaviours. Framework analysis was used to code the data into TDF domains. Results: There is a complex relationship between the factors affecting COVID-19 symptom identification, testing, and self-isolation. People who perceived significant barriers to testing and self-isolation were less likely to interpret potential symptoms as COVID-19, and perceiving barriers to self-isolation reduced the likelihood of requesting a test. Concerns about the negative consequences of self-isolation for themselves and others were common and also influenced willingness to pass on details of contacts. There was a lack of trust in the Test and Trace system, with people wanting further evidence of being at risk of infection. Conclusions: Communications and interventions to increase adherence to test, trace, and isolate strategies need to consider the interplay of these behaviours and their influences and target them collectively. Efforts to promote testing should focus on the range of barriers to self-isolation, especially increasing financial and practical support, and include new messaging to promote symptom identification.
- 22 March 2022
- Published by Springer Nature in BMC Public Health
- Vol. 22  (1) , 1-11
Open AccessAdherence to behaviours associated with the test, trace, and isolate system: an analysis using the theoretical domains framework
Background: The UKâs test, trace, and isolate system are key measures to reduce the impact and spread of COVID-19. However, engagement with and adherence to guidance on testing, self-isolation, and providing details of contacts can be low and interventions are needed. This qualitative study aimed to identify the key factors affecting adherence to test, trace, and isolate behaviours using the Theoretical Domains Framework (TDF). Methods: We conducted six online focus groups between October 2020 and February 2021 with people living in Sheffield who came into close contact with others in work or social settings (N = 30). The focus groups explored capability, opportunity, and motivational barriers to adherence to test, trace, and isolate behaviours. Framework analysis was used to code the data into TDF domains. Results: There is a complex relationship between the factors affecting COVID-19 symptom identification, testing, and self-isolation. People who perceived significant barriers to testing and self-isolation were less likely to interpret potential symptoms as COVID-19, and perceiving barriers to self-isolation reduced the likelihood of requesting a test. Concerns about the negative consequences of self-isolation for themselves and others were common and also influenced willingness to pass on details of contacts. There was a lack of trust in the Test and Trace system, with people wanting further evidence of being at risk of infection. Conclusions: Communications and interventions to increase adherence to test, trace, and isolate strategies need to consider the interplay of these behaviours and their influences and target them collectively. Efforts to promote testing should focus on the range of barriers to self-isolation, especially increasing financial and practical support, and include new messaging to promote symptom identification.
- Open Access
- 12 July 2021
- Published by Center for Open Science in OSF Preprints
Adherence to behaviours associated with the test, trace, and isolate system: An analysis using the Theoretical Domains Framework
Background: The UKâs test, trace, and isolate system are key measures to reduce the impact and spread of the COVID-19. However, engagement with and adherence to guidance on testing, self-isolation, and providing details of contacts can be low and interventions are needed. This qualitative study aimed to identify the key factors affecting adherence to test, trace, and isolate behaviours using the Theoretical Domains Framework (TDF). Methods: We conducted six online focus groups between October 2020 and February 2021 with people living in Sheffield who came into close contact with others in work or social settings (N = 30). The focus groups explored capability, opportunity, and motivational barriers to adherence to test, trace, and isolate behaviours. Framework analysis was used to code the data into TDF domains. Results: There is a complex relationship between the factors affecting COVID-19 symptom identification, testing, and self-isolation. People who perceived significant barriers to testing and self-isolation were less likely to interpret potential symptoms as COVID-19, and perceiving barriers to self-isolation reduced the likelihood of requesting a test. Concerns about the negative consequences of self-isolation for themselves and others were common and also influenced willingness to pass on details of contacts. There was a lack of trust in the Test and Trace system, with people wanting further evidence of being at risk of infection. Conclusions: Communications and interventions to increase adherence to test, trace, and isolate strategies need to consider the interplay of these behaviours and their influences and target them collectively. Efforts to promote testing should focus on the range of barriers to self-isolation, especially increasing financial and practical support, and include new messaging to promote symptom identification.
- 12 July 2021
- Published by Center for Open Science in OSF Preprints
Open AccessAdherence to behaviours associated with the test, trace, and isolate system: An analysis using the Theoretical Domains Framework
Background: The UKâs test, trace, and isolate system are key measures to reduce the impact and spread of the COVID-19. However, engagement with and adherence to guidance on testing, self-isolation, and providing details of contacts can be low and interventions are needed. This qualitative study aimed to identify the key factors affecting adherence to test, trace, and isolate behaviours using the Theoretical Domains Framework (TDF). Methods: We conducted six online focus groups between October 2020 and February 2021 with people living in Sheffield who came into close contact with others in work or social settings (N = 30). The focus groups explored capability, opportunity, and motivational barriers to adherence to test, trace, and isolate behaviours. Framework analysis was used to code the data into TDF domains. Results: There is a complex relationship between the factors affecting COVID-19 symptom identification, testing, and self-isolation. People who perceived significant barriers to testing and self-isolation were less likely to interpret potential symptoms as COVID-19, and perceiving barriers to self-isolation reduced the likelihood of requesting a test. Concerns about the negative consequences of self-isolation for themselves and others were common and also influenced willingness to pass on details of contacts. There was a lack of trust in the Test and Trace system, with people wanting further evidence of being at risk of infection. Conclusions: Communications and interventions to increase adherence to test, trace, and isolate strategies need to consider the interplay of these behaviours and their influences and target them collectively. Efforts to promote testing should focus on the range of barriers to self-isolation, especially increasing financial and practical support, and include new messaging to promote symptom identification.
- Open Access
- 14 June 2021
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 185  (5) , 952-960
Alcohol misuse is associated with poor response to systemic therapies for psoriasis: findings from a prospective multicentre cohort study*
Background Factors that might influence response to systemic treatment for moderate-to-severe psoriasis are varied, and generally, are poorly understood, aside from high body weight, suggesting that other unidentified factors may be relevant in determining response to treatment. The impact of alcohol abuse on treatment response has not been previously investigated. Objective To investigate whether alcohol abuse is associated with poor response to treatment for psoriasis. Methods Prospective cohort study in which response to systemic therapies was assessed using the Psoriasis Area and Severity Index (PASI). The CAGE questionnaire was used to screen for alcohol abuse. A multivariable factional polynomial linear regression model was used to examine factors associated with change in PASI between baseline and follow-up. Results The cohort comprised of 266 patients (biologic cohort, n=134; conventional systemic cohort, n=132). For the entire cohort, the median (interquartile range) PASI improved from 13[10-18.3] at baseline to 3[1-7.5] during follow-up. A higher CAGE score (regression co-efficient: 1.40; 95% CIs: 0.04-2.77); obesity (1.84; 0.48-3.20); and receiving a conventional systemic rather than a biologic therapy (4.39; 2.84-5.95) were significantly associated with poor response to treatment; whereas a higher baseline PASI (-0.83; -0.92,-0.74) was associated with better response to treatment. Conclusion The poor response to therapy associated with alcohol abuse and obesity found in people with psoriasis calls for lifestyle behaviour change interventions and support as part of routine clinical care. Targeting interventions to prevent, detect and manage alcohol abuse among people with psoriasis is needed to minimise adverse health consequences and improve treatment response.
- 14 June 2021
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 185  (5) , 952-960
Open AccessAlcohol misuse is associated with poor response to systemic therapies for psoriasis: findings from a prospective multicentre cohort study*
Background Factors that might influence response to systemic treatment for moderate-to-severe psoriasis are varied, and generally, are poorly understood, aside from high body weight, suggesting that other unidentified factors may be relevant in determining response to treatment. The impact of alcohol abuse on treatment response has not been previously investigated. Objective To investigate whether alcohol abuse is associated with poor response to treatment for psoriasis. Methods Prospective cohort study in which response to systemic therapies was assessed using the Psoriasis Area and Severity Index (PASI). The CAGE questionnaire was used to screen for alcohol abuse. A multivariable factional polynomial linear regression model was used to examine factors associated with change in PASI between baseline and follow-up. Results The cohort comprised of 266 patients (biologic cohort, n=134; conventional systemic cohort, n=132). For the entire cohort, the median (interquartile range) PASI improved from 13[10-18.3] at baseline to 3[1-7.5] during follow-up. A higher CAGE score (regression co-efficient: 1.40; 95% CIs: 0.04-2.77); obesity (1.84; 0.48-3.20); and receiving a conventional systemic rather than a biologic therapy (4.39; 2.84-5.95) were significantly associated with poor response to treatment; whereas a higher baseline PASI (-0.83; -0.92,-0.74) was associated with better response to treatment. Conclusion The poor response to therapy associated with alcohol abuse and obesity found in people with psoriasis calls for lifestyle behaviour change interventions and support as part of routine clinical care. Targeting interventions to prevent, detect and manage alcohol abuse among people with psoriasis is needed to minimise adverse health consequences and improve treatment response.
- Open Access
- 29 January 2021
- Published by Center for Open Science in PsyArXiv
Aspirin use for cancer prevention: a systematic review of public, patient and healthcare provider attitudes and adherence behaviours
Background: Clinical guidelines worldwide are increasingly recommending aspirin for cancer prevention. We undertook a systematic review to synthesise the quantitative and qualitative data on attitudes and behaviour towards the use of aspirin for cancer prevention, and healthcare providersâ attitudes and behaviour towards implementing aspirin in clinical care.Design: In February 2020, we searched: MEDLINE, EMBASE, CINAHL, Web of Science, Cochrane Library, DARE, NHS EED, HTA Database, clinical trial registries and ProQuest Dissertations & Theses. Peer-reviewed studies on the use of aspirin for cancer prevention were included. We used the Mixed Methods Appraisal Tool to evaluate study quality, and conducted a narrative synthesis of the data. The review was pre-registered (PROSPERO: CRD42018093453).Results: Forty-two studies were identified. Uptake and adherence data were all from trials. Trials recruited healthy participants, those at higher risk of cancer (e.g. colorectal), and those with cancer (e.g. breast, colorectal). Four trials reported uptake data, of which three found low to medium uptake rates (3.7-40.9%). Most trials (18/22) reported high day-to-day adherence (â„80%). Among trials reporting data at three years, 38.6-93.6% were still using aspirin at follow-up. Four studies investigated the factors associated with adherence, and none with uptake. Three trials observed no association between gender and adherence levels. One trial found no association between colorectal cancer risk and adherence levels. Three studies observed low rates (3.2-34.5%) of healthcare providers recommending aspirin in clinical practice. No qualitative studies were identified. Conclusion: Most patients and members of the public who are offered aspirin for cancer prevention do not initiate preventive therapy. Day-to-day adherence was high among those using aspirin, but persistence may be a problem where long-term use is required. Further research is needed to identify the factors affecting aspirin use, and the barriers to implementing aspirin into clinical care.
- 29 January 2021
- Published by Center for Open Science in PsyArXiv
Open AccessAspirin use for cancer prevention: a systematic review of public, patient and healthcare provider attitudes and adherence behaviours
Background: Clinical guidelines worldwide are increasingly recommending aspirin for cancer prevention. We undertook a systematic review to synthesise the quantitative and qualitative data on attitudes and behaviour towards the use of aspirin for cancer prevention, and healthcare providersâ attitudes and behaviour towards implementing aspirin in clinical care.Design: In February 2020, we searched: MEDLINE, EMBASE, CINAHL, Web of Science, Cochrane Library, DARE, NHS EED, HTA Database, clinical trial registries and ProQuest Dissertations & Theses. Peer-reviewed studies on the use of aspirin for cancer prevention were included. We used the Mixed Methods Appraisal Tool to evaluate study quality, and conducted a narrative synthesis of the data. The review was pre-registered (PROSPERO: CRD42018093453).Results: Forty-two studies were identified. Uptake and adherence data were all from trials. Trials recruited healthy participants, those at higher risk of cancer (e.g. colorectal), and those with cancer (e.g. breast, colorectal). Four trials reported uptake data, of which three found low to medium uptake rates (3.7-40.9%). Most trials (18/22) reported high day-to-day adherence (â„80%). Among trials reporting data at three years, 38.6-93.6% were still using aspirin at follow-up. Four studies investigated the factors associated with adherence, and none with uptake. Three trials observed no association between gender and adherence levels. One trial found no association between colorectal cancer risk and adherence levels. Three studies observed low rates (3.2-34.5%) of healthcare providers recommending aspirin in clinical practice. No qualitative studies were identified. Conclusion: Most patients and members of the public who are offered aspirin for cancer prevention do not initiate preventive therapy. Day-to-day adherence was high among those using aspirin, but persistence may be a problem where long-term use is required. Further research is needed to identify the factors affecting aspirin use, and the barriers to implementing aspirin into clinical care.
- Open Access
- 20 July 2020
- Published by Center for Open Science in PsyArXiv
Willingness to receive a COVID-19 vaccine among adults at high-risk of COVID-19: a UK-wide survey
PURPOSE Willingness of adults at high-risk of COVID-19 to receive a COVID-19 vaccine is unknown. There are key disparities in the risk and outcomes from COVID-19 by socio-demographic factors, including age, sex, level of deprivation, and ethnicity. A COVID-19 vaccination programme could inadvertently exacerbate these inequalities if it is not readily received by different population groups. In this UK-wide cross-sectional survey, we examined willingness to receive a COVID-19 vaccine in the general population and evaluated socio-demographic and clinical factors associated with willingness.METHODS Between April and June 2020, individuals in the general population were invited to complete an online survey; 2568 provided informed consent. Willingness to receive a COVID-19 vaccine was reported by 2152 (83.8%).RESULTS In total, 76.9% (1654/2152) reported being willing to receive a COVID-19 vaccine. One in five individuals at increased risk of COVID-19, as defined by UK government guidelines, were unwilling to receive a COVID-19 vaccine (119/589; 20.2%). Individuals from white ethnic group were more likely to be willing to receive a COVID-19 vaccine compared with those from BAME groups (79.9% vs. 55.9%, respectively), OR 2.84, 96% CI = 1.93 â 4.18, p †0.001. Willingness did not vary among adults at increased risk of COVID-19 compared with those not at increased risk.CONCLUSION A significant proportion of individuals in the general population are unwilling to receive a COVID-19 vaccine, including those at increased risk of COVID-19 morbidity and mortality. There are socio-demographic differences in willingness, especially by ethnic group. Success of a vaccination programme for COVID-19 depends not only on the efficacy of the vaccine but also on its uptake. Research is urgently needed to establish the most effective policy and communications to encourage maximal uptake of the vaccination.
- 20 July 2020
- Published by Center for Open Science in PsyArXiv
Open AccessWillingness to receive a COVID-19 vaccine among adults at high-risk of COVID-19: a UK-wide survey
PURPOSE Willingness of adults at high-risk of COVID-19 to receive a COVID-19 vaccine is unknown. There are key disparities in the risk and outcomes from COVID-19 by socio-demographic factors, including age, sex, level of deprivation, and ethnicity. A COVID-19 vaccination programme could inadvertently exacerbate these inequalities if it is not readily received by different population groups. In this UK-wide cross-sectional survey, we examined willingness to receive a COVID-19 vaccine in the general population and evaluated socio-demographic and clinical factors associated with willingness.METHODS Between April and June 2020, individuals in the general population were invited to complete an online survey; 2568 provided informed consent. Willingness to receive a COVID-19 vaccine was reported by 2152 (83.8%).RESULTS In total, 76.9% (1654/2152) reported being willing to receive a COVID-19 vaccine. One in five individuals at increased risk of COVID-19, as defined by UK government guidelines, were unwilling to receive a COVID-19 vaccine (119/589; 20.2%). Individuals from white ethnic group were more likely to be willing to receive a COVID-19 vaccine compared with those from BAME groups (79.9% vs. 55.9%, respectively), OR 2.84, 96% CI = 1.93 â 4.18, p †0.001. Willingness did not vary among adults at increased risk of COVID-19 compared with those not at increased risk.CONCLUSION A significant proportion of individuals in the general population are unwilling to receive a COVID-19 vaccine, including those at increased risk of COVID-19 morbidity and mortality. There are socio-demographic differences in willingness, especially by ethnic group. Success of a vaccination programme for COVID-19 depends not only on the efficacy of the vaccine but also on its uptake. Research is urgently needed to establish the most effective policy and communications to encourage maximal uptake of the vaccination.
- Open Access
- 13 July 2020
- Published by Center for Open Science in PsyArXiv
What influences peopleâs responses to public health messages for managing risks and preventing infectious diseases? A rapid systematic review of the evidence and recommendations
Background Population level behaviour change, requiring individual behaviour change such as hand hygiene and physical distancing, are central to reducing transmission of infectious diseases, including COVID-19, but little is known about how best to communicate this type of risk reducing information, and how populations might respond. We conducted a rapid systematic review to identify and synthesise evidence relating to: a) What characterises effective public-health messages for managing risk and preventing infectious disease, and b) What influences peopleâs responses to public-health messages.Methods Rapid systematic review methodology was used. We included all study designs and grey literature. Non-English language papers were excluded. Ovid Medline, Ovid PsycINFO and Healthevidence.org were searched alongside PsyarXiv and OSF Preprints up to May 2020. A narrative synthesis was conducted.Findings We identified 70 eligible papers: 3 systematic reviews, 54 individual papers and 14 pre-prints. To influence behaviour effectively at the population level, public-health messages need to be acceptable, credible and trustworthy, to increase the publicâs understanding and perceptions of the threat. Interpretation Key recommendations are to: engage communities in the development of public-health messaging, use credible and legitimate sources, address uncertainty immediately and with transparency, focus on unifying messages from all sources, and develop messages aimed at increasing understanding, induce social responsibility and empower personal control. Embedding these principles of behavioural science into public-health messaging is an important step towards more effective health-risk communication for managing risk, promoting protective behaviours and preventing disease during epidemics/pandemics.
- 13 July 2020
- Published by Center for Open Science in PsyArXiv
Open AccessWhat influences peopleâs responses to public health messages for managing risks and preventing infectious diseases? A rapid systematic review of the evidence and recommendations
Background Population level behaviour change, requiring individual behaviour change such as hand hygiene and physical distancing, are central to reducing transmission of infectious diseases, including COVID-19, but little is known about how best to communicate this type of risk reducing information, and how populations might respond. We conducted a rapid systematic review to identify and synthesise evidence relating to: a) What characterises effective public-health messages for managing risk and preventing infectious disease, and b) What influences peopleâs responses to public-health messages.Methods Rapid systematic review methodology was used. We included all study designs and grey literature. Non-English language papers were excluded. Ovid Medline, Ovid PsycINFO and Healthevidence.org were searched alongside PsyarXiv and OSF Preprints up to May 2020. A narrative synthesis was conducted.Findings We identified 70 eligible papers: 3 systematic reviews, 54 individual papers and 14 pre-prints. To influence behaviour effectively at the population level, public-health messages need to be acceptable, credible and trustworthy, to increase the publicâs understanding and perceptions of the threat. Interpretation Key recommendations are to: engage communities in the development of public-health messaging, use credible and legitimate sources, address uncertainty immediately and with transparency, focus on unifying messages from all sources, and develop messages aimed at increasing understanding, induce social responsibility and empower personal control. Embedding these principles of behavioural science into public-health messaging is an important step towards more effective health-risk communication for managing risk, promoting protective behaviours and preventing disease during epidemics/pandemics.
- Open Access
- 30 April 2020
- Published by Center for Open Science in PsyArXiv
SCOPING REVIEW OF MOBILE PHONE APP UPTAKE AND ENGAGEMENT TO INFORM DIGITAL CONTACT TRACING TOOLS FOR COVID-19
BACKGROUNDDigital contact tracing apps have been proposed as a method of controlling the spread of Covid-19. The effectiveness of this tool depends largely on adequate levels of uptake (e.g. whether the user downloads and registers on the application) and engagement (e.g. the extent of usage of the application or its components over time). It has been estimated that approximately 60% of the population would need to use the NHSX application in order for it to be effective in reducing the spread of COVID-19. It is therefore crucial that we understand the level of, and factors influencing, uptake and engagement with digital tracing applications in order to put appropriate measures in place to mitigate those issues.AIMS1.To quantify the current data on COVID-19 digital contact tracing applicationsa.Uptake and engagement of COVID-19 digital contact tracing applicationsb.Examine whether uptake differs between countries c.Identify any predictors or correlates of uptake and engagement2.To conduct two scoping reviews to identify key barriers and facilitators influencing engagement and uptake of a.COVID-19 digital contact tracing applications b.Health behaviour change applications, including government approved applications, from academic literature and behaviour change guidelinesCONCLUSIONSâąThere is no evidence on the level of uptake and engagement with COVID-19 digital contact tracing applications.âąThere is a dearth of evidence regarding the barriers and facilitators to uptake and engagement with COVID-19 digital contact tracing applications.âąThe health behaviour change literature suggests a number of barriers and facilitators associated with uptake and engagement with applications.
- 30 April 2020
- Published by Center for Open Science in PsyArXiv
Open AccessSCOPING REVIEW OF MOBILE PHONE APP UPTAKE AND ENGAGEMENT TO INFORM DIGITAL CONTACT TRACING TOOLS FOR COVID-19
BACKGROUNDDigital contact tracing apps have been proposed as a method of controlling the spread of Covid-19. The effectiveness of this tool depends largely on adequate levels of uptake (e.g. whether the user downloads and registers on the application) and engagement (e.g. the extent of usage of the application or its components over time). It has been estimated that approximately 60% of the population would need to use the NHSX application in order for it to be effective in reducing the spread of COVID-19. It is therefore crucial that we understand the level of, and factors influencing, uptake and engagement with digital tracing applications in order to put appropriate measures in place to mitigate those issues.AIMS1.To quantify the current data on COVID-19 digital contact tracing applicationsa.Uptake and engagement of COVID-19 digital contact tracing applicationsb.Examine whether uptake differs between countries c.Identify any predictors or correlates of uptake and engagement2.To conduct two scoping reviews to identify key barriers and facilitators influencing engagement and uptake of a.COVID-19 digital contact tracing applications b.Health behaviour change applications, including government approved applications, from academic literature and behaviour change guidelinesCONCLUSIONSâąThere is no evidence on the level of uptake and engagement with COVID-19 digital contact tracing applications.âąThere is a dearth of evidence regarding the barriers and facilitators to uptake and engagement with COVID-19 digital contact tracing applications.âąThe health behaviour change literature suggests a number of barriers and facilitators associated with uptake and engagement with applications.
- 1 April 2020
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 13  (4) , 411-422
Knowledge of Potential Harms and Benefits of Tamoxifen among Women Considering Breast Cancer Preventive Therapy
Tamoxifen reduces breast cancer incidence in women at increased risk, but may cause side effects. We examined women's knowledge of tamoxifen's potential harms and benefits, and the extent to which knowledge reflects subjective judgments of awareness and decision quality. After a hospital appointment, 408 (55.7%) women at increased risk of breast cancer completed a survey assessing objective knowledge about the potential benefit (risk reduction) and harms (endometrial cancer, thromboembolic events, and menopausal side effects) of tamoxifen, and subjective tamoxifen knowledge and decisional quality. Two hundred fifty-eight (63.2%) completed a 3-month follow-up survey. Sixteen percent (15.7%) of participants recognized the potential benefit and three major harms of using tamoxifen. These women were more likely to have degree-level education [vs. below degree level; OR, 2.24; 95% confidence interval (CI), 1.11â4.55] and good numeracy (vs. poor numeracy; OR, 5.91; 95% CI, 1.33â26.19). Tamoxifen uptake was higher in women who recognized all harms and benefits (vs. not recognizing; OR, 2.47; 95% CI, 0.94â6.54). Sixty-six percent (65.8%) of tamoxifen users were unaware of its potential benefit and harms. Most (87.1%) women reported feeling informed about tamoxifen, and subjective decisional quality was high [Mean (SD), 17.03 (1.87), out of 18]. Knowledge regarding the potential harms and benefit of tamoxifen is low in women considering prevention therapy, and they may need additional support to make informed decisions about tamoxifen preventive therapy.
- 1 April 2020
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 13  (4) , 411-422
Knowledge of Potential Harms and Benefits of Tamoxifen among Women Considering Breast Cancer Preventive Therapy
Tamoxifen reduces breast cancer incidence in women at increased risk, but may cause side effects. We examined women's knowledge of tamoxifen's potential harms and benefits, and the extent to which knowledge reflects subjective judgments of awareness and decision quality. After a hospital appointment, 408 (55.7%) women at increased risk of breast cancer completed a survey assessing objective knowledge about the potential benefit (risk reduction) and harms (endometrial cancer, thromboembolic events, and menopausal side effects) of tamoxifen, and subjective tamoxifen knowledge and decisional quality. Two hundred fifty-eight (63.2%) completed a 3-month follow-up survey. Sixteen percent (15.7%) of participants recognized the potential benefit and three major harms of using tamoxifen. These women were more likely to have degree-level education [vs. below degree level; OR, 2.24; 95% confidence interval (CI), 1.11â4.55] and good numeracy (vs. poor numeracy; OR, 5.91; 95% CI, 1.33â26.19). Tamoxifen uptake was higher in women who recognized all harms and benefits (vs. not recognizing; OR, 2.47; 95% CI, 0.94â6.54). Sixty-six percent (65.8%) of tamoxifen users were unaware of its potential benefit and harms. Most (87.1%) women reported feeling informed about tamoxifen, and subjective decisional quality was high [Mean (SD), 17.03 (1.87), out of 18]. Knowledge regarding the potential harms and benefit of tamoxifen is low in women considering prevention therapy, and they may need additional support to make informed decisions about tamoxifen preventive therapy.
- Open Access
- 15 August 2019
- Published by Center for Open Science in PsyArXiv
Knowledge of potential harms and benefits of tamoxifen among women considering breast cancer preventive therapy
Tamoxifen reduces breast cancer incidence in women at increased risk, but may cause side-effects. We examined womenâs knowledge of tamoxifenâs potential harms and benefits, and the extent to which knowledge reflects subjective judgements of awareness and decision quality. After a hospital appointment, 408 (55.7%) women at increased risk of breast cancer completed a survey assessing objective knowledge about the potential benefit (risk reduction) and harms (endometrial cancer, thromboembolic events, and menopausal side-effects) of tamoxifen, and subjective tamoxifen knowledge and decisional quality. 258 (63.2%) completed a 3-month follow-up survey. 15.7% of participants recognised the potential benefit and three major harms of using tamoxifen. These women were more likely to have degree level education (vs. below degree level) (OR=2.24, 95%CI: 1.11-4.55) and good numeracy (vs. poor numeracy) (OR=5.91, 95%CI: 1.33-26.19). Tamoxifen uptake was higher in women who recognised all harms and benefits (vs. not recognising) (OR=2.47, 95%CI: 0.94â6.54). 65.8% of tamoxifen users were unaware of its potential benefit and harms. Most (87.1%) women reported feeling informed about tamoxifen, and subjective decisional quality was high (Mean [SD], 17.03 [1.87], out of 18). Knowledge regarding the potential harms and benefit of tamoxifen is low in women considering prevention therapy, and they may need additional support to make informed decisions about tamoxifen preventive therapy.
- 15 August 2019
- Published by Center for Open Science in PsyArXiv
Open AccessKnowledge of potential harms and benefits of tamoxifen among women considering breast cancer preventive therapy
Tamoxifen reduces breast cancer incidence in women at increased risk, but may cause side-effects. We examined womenâs knowledge of tamoxifenâs potential harms and benefits, and the extent to which knowledge reflects subjective judgements of awareness and decision quality. After a hospital appointment, 408 (55.7%) women at increased risk of breast cancer completed a survey assessing objective knowledge about the potential benefit (risk reduction) and harms (endometrial cancer, thromboembolic events, and menopausal side-effects) of tamoxifen, and subjective tamoxifen knowledge and decisional quality. 258 (63.2%) completed a 3-month follow-up survey. 15.7% of participants recognised the potential benefit and three major harms of using tamoxifen. These women were more likely to have degree level education (vs. below degree level) (OR=2.24, 95%CI: 1.11-4.55) and good numeracy (vs. poor numeracy) (OR=5.91, 95%CI: 1.33-26.19). Tamoxifen uptake was higher in women who recognised all harms and benefits (vs. not recognising) (OR=2.47, 95%CI: 0.94â6.54). 65.8% of tamoxifen users were unaware of its potential benefit and harms. Most (87.1%) women reported feeling informed about tamoxifen, and subjective decisional quality was high (Mean [SD], 17.03 [1.87], out of 18). Knowledge regarding the potential harms and benefit of tamoxifen is low in women considering prevention therapy, and they may need additional support to make informed decisions about tamoxifen preventive therapy.